Cleared Special

K260437 - Valvuloplasty Balloon Catheter (ValvuloPro) (FDA 510(k) Clearance)

Mar 2026
Decision
37d
Days
Class 2
Risk

K260437 is an FDA 510(k) clearance for the Valvuloplasty Balloon Catheter (ValvuloPro). This device is classified as a Balloon Aortic Valvuloplasty (Class II - Special Controls, product code OZT).

Submitted by Dongguan TT Medical, Inc. (Dongguan, CN). The FDA issued a Cleared decision on March 20, 2026, 37 days after receiving the submission on February 11, 2026.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1255. A Balloon Aortic Valvuloplasty Catheter Is Indicated For Balloon Valvuloplasty Of The Aortic Valve..

Submission Details

510(k) Number K260437 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 11, 2026
Decision Date March 20, 2026
Days to Decision 37 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code OZT — Balloon Aortic Valvuloplasty
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1255
Definition A Balloon Aortic Valvuloplasty Catheter Is Indicated For Balloon Valvuloplasty Of The Aortic Valve.